Javier L. Munoz, MD, MS, FACP

home / authors / javier-l-munoz-md-ms-facp

Articles

$This special episode of “Oncology Peer Review On-The-Go” includes a discussion on relapsed/refractory follicular lymphoma with Javier Munoz, MD, MS, FACP.$

OncView™ Podcast: Updates in Therapies for Relapsed/Refractory Follicular Lymphoma

Matthew Fowler;Javier L. Munoz, MD, MS, FACP

August 29th 2021

This special episode of “Oncology Peer Review On-The-Go” includes a discussion on relapsed/refractory follicular lymphoma with Javier Munoz, MD, MS, FACP.

Changes in Sequencing of R/R FL Therapies

Javier L. Munoz, MD, MS, FACP;Kristie L. Kahl

July 20th 2021

Javier L. Munoz, MD, MS, FACP, discusses how the sequencing of therapies has changed in the last year.

Use of Tazemetostat for R/R FL

Javier L. Munoz, MD, MS, FACP;Kristie L. Kahl

July 13th 2021

An expert in relapsed/refractory follicular lymphoma discusses the approval of tazemetostat as a treatment and reviews the phase 2 clinical trial data.

Treatment Options for Third Line R/R FL

Javier L. Munoz, MD, MS, FACP;Kristie L. Kahl

July 13th 2021

Javier L. Munoz, MD, MS, FACP, describes the current third-line treatment options available for relapsed/refractory follicular lymphoma.

$Factors in Choosing Relapsed/Refractory Follicular Lymphoma Treatments$

Factors in Choosing Relapsed/Refractory Follicular Lymphoma Treatments

Javier L. Munoz, MD, MS, FACP;Kristie L. Kahl

July 6th 2021

A specialist explains the factors considered when it comes to choosing treatments for patients with relapsed/refractory follicular lymphoma, and the clinical endpoints to look for.

$Current Treatment Options for Relapsed/Refractory Follicular Lymphoma$

Current Treatment Options for Relapsed/Refractory Follicular Lymphoma

Javier L. Munoz, MD, MS, FACP;Kristie L. Kahl

July 6th 2021

Javier L. Munoz, MD, MS, FACP, describes the effects of R/R FL and discusses the current treatment options available.